Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 6806-6812

  Li, Nianyu ^a   Workman, Creg J ^a   Martin, Stefani M ^a   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; PEPTIDE FRAGMENT; REGULATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; CHEMICAL ANALYSIS; CONTROLLED STUDY; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE ACTIVATION GENE 3;

EID: 9144255487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.6806     Document Type: Article

References (25)

1. Hannier, S., M. Tournier, G. Bismuth, and F. Triebel. 1998. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J. Immunol. 161:4058.
2. Triebel, F. 2003. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol. 24:619.
3. Workman, C. J., and D. A. Vignali. 2003. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur. J. Immunol 33:970.
4. Workman, C. J., K. J. Dugger, and D. A. Vignali. 2002. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J. Immunol. 169:5392.
5. Workman, C. J., L. S. Cauley, I. J. Kim, M. A. Blackman, D. L. Woodland, and D. A. Vignali. 2004. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J. Immunol 172:5450.
6. Huang, C. T., C. J. Workman, D. Flies, X. Pan, A. L. Marson, G. Zhou, E. L. Hipkiss, S. Ravi, J. Kowalski, H. I. Levitsky, et al. Role of LAG-3 in Regulatory T Cells. Immunity. In press.
7. Triebel, P., S. Jitsukawa, E. Baixeras, S. Roman-Roman, C. Genevee, E. Viegas-Pequignot, and T. Hercend. 1990. LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 171:1393.
8. Bruniquel, D., N. Borie, and F. Triebel. 1997. Genomic organization of the human LAG-3/CD4 locus. Immunogenetics 47:96.
9. Baixeras, E., B. Huard, C. Miossec, S. Jitsukawa, M. Martin, T. Hercend, C. Auffray, F. Triebel, and D. Piatier-Tonneau. 1992. Characterization of the lymphocyte activation gene 3-encoded protein: a new ligand for human leukocyte antigen class II antigens. J. Exp. Med. 176:327.
10. Huard, B., P. Gaulard, F. Faure, T. Hercend, and F. Triebel. 1994. Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics 39:213.
11. Workman, C. J., D. S. Rice, K. J. Dugger, C. Kurschner, and D. A. Vignali. 2002. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur. J. Immunol. 32:2255.
12. + T lymphocytes. Eur. J. Immunol 24:3216.
13. Huard, B., P. Prigent, M. Tournier, D. Bruniquel, and F. Triebel. 1995. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 25:2718.
14. Huard, B., R. Mastrangeli, P. Prigent, D. Bruniquel, S. Donini, N. El Tayar, B. Maigret, M. Dreano, and F. Triebel. 1997. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Proc. Natl. Acad. Sci. USA 94:5744.
15. Andreae, S., F. Piras, N. Burdin, and F. Triebel. 2002. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J. Immunol. 168:3874.
16. Andreae, S., S. Buisson, and F. Triebel. 2003. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102:2130.
17. + T cells are associated with IFN-γ production. FASEB J. 10:769.
18. Lienhardt, C., A. Azzurri, A. Amedei, K. Fielding, J. Sillah, O. Y. Sow, B. Bah, M. Benagiano, A. Diallo, R. Manetti, et al. 2002. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur. J. Immunol. 32:1605.
19. Allen, P. M., D. J. McKean, B. N. Beck, J. Sheffield, and L. H. Glimcher. 1985. Direct evidence that a class II molecule and a simple globular protein generate multiple determinants. J. Exp. Med. 162:1264.
20. Vignali, D. A., and J. L. Strominger. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179:1945.
21. La Gruta, N. L., H. Liu, S. Dilioglou, M. Rhodes, D. L. Wiest, and D. A. Vignali. 2004. Architectural changes in the TCR:CD3 complex induced by MHC:peptide ligation. J. Immunol. 172:3662.
22. Liu, H., M. Rhodes, D. L. Wiest, and D. A. Vignali. 2000. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 13:665.
23. Annunziato, P., R. Manetti, L. Cosmi, G. Galli, C. H. Heusser, S. Romagnani, and E. Maggi. 1997. Opposite role for interleukin-4 and interferon-γ on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur. J. Immunol 27:2239.
24. Scala, E., M. Carbonari, P. Del Porto, M. Cibati, T. Tedesco, A. M. Mazzone, R. Paganelli, and M. Fiorilli. 1998. Lymphocyte activation gene-3 (LAG-3) expression and IFN-γ production are variably coregulated in different human T lymphocyte subpopulations. J. Immunol 161:489.
25. Wu, H., P. D. Kvvong, and W. A. Hendrickson. 1997. Dimeric association and segmental variability in the structure of human CD4. Nature 387:527.